PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, featuring promising improvements across a variety of healthcare and industrial apps. With its structural similarity to Normally derived human serum albumin, OsrHSA offers a safer, additional dependable substitute for therapeutic use,